Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed Papers

Active Biotech announce that European Medicines Agency accepts start of scientific review of the marketing authorization application for laquinimod in relapsing-remitting multiple sclerosis
Multiple sclerosis: Spinal cord grey matter loss correlates with disability in MS.
An observational comparison of natalizumab vs. fingolimod using JCV serology to determine therapy.
The effects of intrathecal rituximab on biomarkers in multiple sclerosis.
Review of subcutaneous interferon β-1a, delivered via the electronic self-injection device RebiSmart™, for the treatment of multiple sclerosis.
A telerehabilitation program by virtual reality-video games improves balance and postural control in multiple sclerosis patients.
Potential T cell epitopes of Mycobacterium tuberculosis that can instigate molecular mimicry against host: implications in autoimmune pathogenesis.
Low-contrast visual tests reveal better alemtuzumab efficacy
Do positive or negative stressful events predict the development of new brain lesions in people with multiple sclerosis?
The effect of cannabinoids on the stretch reflex in multiple sclerosis spasticity.
Basis for fluctuations in lymphocyte counts in fingolimod-treated patients with multiple sclerosis.
Benign Multiple Sclerosis: Does it exist?
Comprehending the inexplicable: qualitative accounts of black Caribbean and white british people severely affected by multiple sclerosis.
From "Wheelchair Circuit" to "Wheelchair Assessment Instrument for People with Multiple Sclerosis": Reliability and Validity Analysis of a Test to Assess Driving Skills in Manual Wheelchair Users With Multiple Sclerosis.
Cancer risk in multiple sclerosis: findings from British Columbia, Canada.
B cells from glatiramer acetate-treated mice suppress experimental autoimmune encephalomyelitis.
Early activation of CD4+ and CD8+ T lymphocytes by myelin basic protein in subjects with MS.
Sodium accumulation is associated with disability and a progressive course in multiple sclerosis.
A major histocompatibility Class I locus contributes to multiple sclerosis susceptibility independently from HLA-DRB1*15:01.
A Study to Evaluate the Long-term Safety, Tolerability and Effect of Daily Oral Laquinimod 0.6 mg on Disease Course in Subjects With Relapsing Multiple Sclerosis
Diagnosis of exclusion: a case report of probable glatiramer acetate-induced eosinophilic myocarditis.
Don't stress about it!: Is stress management a disease-modifying therapy for multiple sclerosis?
Materials for stem cell factories of the future.
DemTect, PANDA, EASY, and MUSIC: Cognitive Screening Tools with Age Correction and Weighting of Subtests According to Their Sensitivity and Specificity.
HERV-W envelope protein inhibits oligodendroglial precursor cell differentiation.

Pages